Eli Lilly (LLY), Pfizer (PFE), and Johnson & Johnson (JNJ) secured spots on China's first innovative drug catalog for private insurance, featuring 19 high-cost medicines for conditions like cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback